Toronto, Ontario, July 14, 2022 (GLOBE NEWSWIRE) — LifeLabs has been named one of Canada’s Best Employers for Diversity in 2022 by Forbes.
This prestigious award was presented by Forbes in partnership with Statista, the world-leading statistics portal and industry ranking provider. The Best Employer’s for Diversity list recognizes Canadian companies that have demonstrated a significant commitment to a defined strategy to foster and promote diversity, equity, inclusion and accessibility in their workplace culture, recruitment practices and employee education and training. LifeLabs was listed as #46 out of 150 Canadian companies.
Recipients were selected based on the assessments of approximately 10,000 professionals working for companies employing at least 500 people in their Canadian operations were surveyed to identify Canada’s Best Employers for Diversity. The following four criteria were taken into consideration:
“To be recognized by Canadians, our employees and peers as an organization that promotes a culture of awareness, respect, and integrity, and that is actively working toward achieving equity, both in our workplaces and the larger communities we serve, is a great honour,” shared LifeLabs President and CEO, Charles Brown.
“While we have made considerable progress on our journey to be a DEI-informed organization, we know that, through our Stronger Together program, we can and will do more to further our commitment to building an inclusive workplace and healthcare environment for Canadians.”
LifeLabs’ continued investment in a comprehensive DE&I strategy has brought forth valuable programs, initiatives, and leadership that continue to make meaningful impacts and facilitate future development and innovation in this area:
In partnership with leading DE&I organizations, such as the Canadian Centre for Diversity and Inclusion, as well as Pride at Work, LifeLabs has invested in educational resources and events on DE&I topics for our employees. These resources, such as our Gender Diversity Education modules, will provide our employees with the knowledge, language, and skills to truly embody our values and commitment to diversity, equity, and inclusion.
In keeping with our mission to invest in equity-building initiatives both inside our organization and within our larger communities, LifeLabs has also partnered with Indspire to establish a bursary program to promote educational opportunities in the healthcare sector for Indigenous youth. As Canada’s largest community laboratory, we want to lead the way in creating an environment that is accessible and equitable for all employees and customers alike. We recognize and appreciate the diverse experiences of our teams, and the value that brings to building an inclusive environment for our customers. More information about LifeLabs’ DE&I initiatives can be found at: https://www.lifelabs.com/about-us/diversity-equity-inclusion/. To learn more about this award and to see the complete list of recipients, please visit the Forbes website.
About LifeLabs
LifeLabs is Canada’s leading provider of laboratory diagnostic information and digital health connectivity systems, enabling patients and health care practitioners to diagnose, treat, monitor, and prevent disease. We support 20 million patient visits annually and conduct over 100 million laboratory tests through leading edge technologies and our 6,500 talented and dedicated employees. We are a committed innovator in supporting Canadians to live healthier lives, operating Canada’s first commercial genetics lab, and the country’s largest online patient portal, with more than 5 million Canadians receiving their results online. LifeLabs has been named one of Canada’s Best Employers (2021 and 2022) and Best Employers for Diversity (2022) by Forbes, and recognized for having an award-winning Mental Health Program from Benefits Canada. LifeLabs is 100% Canadian owned by OMERS Infrastructure, the infrastructure investment manager of one of Canada’s largest defined benefit pension plans. Learn more at lifelabs.com.
CONTACT: Communications team LifeLabs communications@lifelabs.com
Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…
BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…
HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…
Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…
Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…